Semax

Description

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), modified with a short C-terminal addition to extend its stability, and studied extensively in neuropeptide research.

In laboratory research, Semax is examined for its proposed effects on brain-derived neurotrophic factor (BDNF) expression and central nervous system signaling pathways associated with neuroprotection and cognitive function.

Researchers studying Semax often focus on its activity independent of classical corticotropic hormonal effects, since despite its ACTH-derived origin it is not associated with adrenal steroidogenesis, making it a useful tool for isolating neurotrophic signaling from endocrine stress-axis activity.

Semax is frequently referenced in comparative neuropeptide research alongside other nootropic-class research peptides to examine structure-activity relationships within CNS-active peptide fragments.

Semax is supplied strictly for laboratory research into neurotrophic signaling, central nervous system pharmacology, and peptide neuroscience.